[1]
R. L. Rauck, MD, “The ACTION study: A randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA®) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin®) for the treatment of chronic, moderate to severe low back pain”, J of Opioid Management, vol. 2, no. 3, pp. 155–166, May 2006.